Formulation of polylactide-co-glycolic acid nanospheres for encapsulation and sustained release of poly(ethylene imine)-poly(ethylene glycol) copolymers complexed to oligonucleotides

Journal of Nanobiotechnology

Volumn 7, Issue , 2009, Pages

  Sirsi, Shashank R ^b   Schray, Rebecca C ^a   Wheatley, Margaret A ^b   Lutz, Gordon J ^a  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDES; AVERAGE DIAMETERS; BIO DISTRIBUTIONS; BURST RELEASE; CATIONIC CHARGES; DOUBLE EMULSIONS; DYSTROPHIN; ENCAPSULATION EFFICIENCIES; END-CAPPING; GLYCOLIC ACIDS; INTRA-MUSCULAR INJECTIONS; KINETIC MEASUREMENTS; MURINE MODELS; MUSCLE FIBERS; MUSCULAR DYSTROPHIES; NON IONICS; PLGA NANO-SPHERES; POLY(ETHYLENE GLYCOL); POLY(ETHYLENEIMINE); POLYETHYLENE IMINES; POLYLACTIDE; POLYPLEXES; POSITIVE SURFACE CHARGES; SKELETAL MUSCLES; SUSTAINED RELEASE; THERAPEUTIC POTENTIALS; ZETA POTENTIAL MEASUREMENTS;

ACIDS; ARCTIC ENGINEERING; COPOLYMERIZATION; COPOLYMERS; EMULSIFICATION; ENCAPSULATION; ESTERS; ETHYLENE; ETHYLENE GLYCOL; MUSCLE; NANOPARTICLES; NANOSPHERES; NITROGEN COMPOUNDS; OLIGONUCLEOTIDES; POLYETHYLENE OXIDES; POLYMERS; SODIUM COMPOUNDS; ZETA POTENTIAL;

POLYETHYLENE GLYCOLS;

ANTISENSE OLIGONUCLEOTIDE; DYSTROPHIN; MACROGOL; NANOSPHERE; POLYETHYLENEIMINE; POLYGLACTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DUCHENNE MUSCULAR DYSTROPHY; GENE EXPRESSION; MALE; MOUSE; MUSCLE CELL; NANOEMULSION; NANOENCAPSULATION; NONHUMAN; PARTICLE SIZE; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION;

MURINAE; MUS;

EID: 65449140272     PISSN: None     EISSN: 14773155     Source Type: Journal    
DOI: 10.1186/1477-3155-7-1     Document Type: Article

References (53)

1. Sazani P Kole R Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing J Clin Invest 2003, 112:481-486. 171400 12925686
2. van Deutekom JC Gene Therapy: The 'pro-sense' approach to Duchenne muscular dystrophy Eur J Hum Genet 2005, 13:518-519. 10.1038/ sj.ejhg.5201381 15714219
3. Bremmer-Bout M Aartsma-Rus A de Meijer EJ Kaman WE Janson AA Vossen RH van Ommen GJ den Dunnen JT van Deutekom JC Targeted exon skipping in transgenic hDMD mice: A model for direct preclinical screening of human-specific antisense oligonucleotides Mol Ther 2004, 10:232-240. 10.1016/j.ymthe.2004.05.031 15294170
4. Ravichandran LV Dean NM Marcusson EG Use of antisense oligonucleotides in functional genomics and target validation Oligonucleotides 2004, 14:49-64. 10.1089/154545704322988058 15104896
5. Goodchild J Oligonucleotide therapeutics: 25 years agrowing Curr Opin Mol Ther 2004, 6:120-128. 15195922
6. Aartsma-Rus A Bremmer-Bout M Janson AA den Dunnen JT van Ommen GJ van Deutekom JC Targeted exon skipping as a potential gene correction therapy for Duchenne muscular dystrophy Neuromuscul Disord 2002, 12(Suppl. 1):S71-S77. 10.1016/S0960-8966(02)00086-X 12206800
7. Wells KE Fletcher S Mann CJ Wilton SD Wells DJ Enhanced in vivo delivery of antisense oligonucleotides to restore dystrophin expression in adult mdx mouse muscle FEBS Lett 2003, 552:145-149. 10.1016/ S0014-5793(03)00904-9 14527677
8. Mann CJ Honeyman K Cheng AJ Ly T Lloyd F Fletcher S Morgan JE Partridge TA Wilton SD Antisense-induced exon skipping and synthesis of dystrophin in the mdx mouse Proc Natl Acad Sci USA 2001, 98:42-47. 14541 11120883 10.1073/pnas.011408598
9. Fletcher S Honeyman K Fall AM Harding PL Johnsen RD Wilton SD Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide J Gene Med 2006, 8(2):207-16. 10.1002/jgm.838 16285002
10. Boussif O Lezoualc'h F Zanta MA Mergny MD Scherman D Demeneix B Behr JP A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: Polyethylenimine Proc Natl Acad Sci USA 1995, 92:7297-7301. 41326 7638184 10.1073/pnas.92.16.7297
11. Bieber T Meissner W Kostin S Niemann A Elsasser HP Intracellular route and transcriptional competence of polyethylenimine-DNA complexes J Control Release 2002, 82:441-454. 10.1016/S0168-3659(02)00129-3 12175756
12. Suh J Wirtz D Hanes J Efficient active transport of gene nanocarriers to the cell nucleus Proc Natl Acad Sci USA 2003, 100:3878-3882. 153016 12644705 10.1073/pnas.0636277100
13. Petersen H Fechner PM Fischer D Kissel T Synthesis, Characterization, and Biocompatibility of Polyethylenimine-graft-poly(ethylene glycol) Block Copolymers Macromolecules 2002, 35:6867-6874. 10.1021/ma012060a
14. Petersen H Fechner PM Martin AL Kunath K Stolnik S Roberts CJ Fischer D Davies MC Kissel T Polyethylenimine-graft-poly(ethylene glycol) copolymers: Influence of copolymer block structure on DNA complexation and biological activities as gene delivery system Bioconjug Chem 2002, 13:845-854. 10.1021/bc025529v 12121141
15. Kichler A Gene transfer with modified polyethylenimines J Gene Med 2004, 6(Suppl 1):S3-10. 10.1002/jgm.507 14978746
16. Thomas M Klibanov AM Non-viral gene therapy: Polycation-mediated DNA delivery Appl Microbiol Biotechnol 2003, 62:27-34. 10.1007/ s00253-003-1321-8 12719940
17. Godbey WT Wu KK Mikos AG Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery Proc Natl Acad Sci USA 1999, 96:5177-5181.
18. Sung SJ Min SH Cho KY Lee S Min YJ Yeom YI Park JK Effect of polyethylene glycol on gene delivery of polyethylenimine Biol Pharm Bull 2003, 26:492-500. 10.1248/bpb.26.492 12673031
19. Hara-Chikuma M Yang B Sonawane ND Sasaki S Uchida S Verkman AS ClC-3 chloride channels facilitate endosomal acidification and chloride accumulation J Biol Chem 2005, 280:1241-1247. 10.1074/jbc.M407030200 15504734
20. Sonawane ND Szoka FC Jr Verkman AS Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes J Biol Chem 2003, 278:44826-44831. 10.1074/jbc.M308643200 12944394
21. Akinc A Thomas M Klibanov AM Langer R Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis J Gene Med 2005, 7:657-663. 10.1002/jgm.696 15543529
22. Brus C Petersen H Aigner A Czubayko F Kissel T Physicochemical and biological characterization of polyethylenimine-graft-poly(ethylene glycol) block copolymers as a delivery system for oligonucleotides and ribozymes Bioconjug Chem 2004, 15:677-684. 10.1021/bc034160m 15264853
23. Schiffelers RM Ansari A Xu J Zhou Q Tang Q Storm G Molema G Lu PY Scaria PV Woodle MC Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle Nucleic Acids Res 2004, 32:e149. 528817 15520458 10.1093/nar/gnh140
24. Williams JH Sirsi SR Latta D Lutz GJ Induction of dystrophin expression by exon skipping in mdx mice following intramuscular injection of antisense oligonucleotides complexed with PEG-PEI copolymers Mol Ther 2006, 14(1):88-96. 10.1016/j.ymthe.2005.11.025 16488666
25. Williams JH Schray RC Sirsi SR Lutz GJ Nanopolymers improve delivery of exon skipping oligonucleotides and concomitant dystrophin expression in skeletal muscle of mdx mice BMC Biotechnol 2008, 8:35. 2362111 18384691 10.1186/1472-6750-8-35
26. Lu QL Bou-Gharios G Partridge TA Non-viral gene delivery in skeletal muscle: A protein factory Gene Ther 2003, 10:131-142. 10.1038/ sj.gt.3301874 12571642
27. Ogris M Brunner S Schuller S Kircheis R Wagner E PEGylated DNA/ transferrin-PEI complexes: Reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery Gene Ther 1999, 6:595-605. 10.1038/sj.gt.3300900 10476219
28. Bala I Hariharan S Kumar MN PLGA nanoparticles in drug delivery: The state of the art Crit Rev Ther Drug Carrier Syst 2004, 21:387-422. 10.1615/CritRevTherDrugCarrierSyst.v21.i5.20 15719481
29. Panyam J Labhasetwar V Targeting intracellular targets Curr Drug Deliv 2004, 1:235-247. 10.2174/1567201043334768 16305387
30. Mundargi RC Babu VR Rangaswamy V Patel P Aminabhavi TM Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives J Control Release 2008, 125:193-209. 10.1016/j.jconrel.2007.09.013 18083265
31. Astete CE Sabliov CM Synthesis and characterization of PLGA nanoparticles J Biomater Sci Polym Ed 2006, 17:247-289. 10.1163/ 156856206775997322 16689015
32. Panyam J Labhasetwar V Biodegradable nanoparticles for drug and gene delivery to cells and tissue Adv Drug Deliv Rev 2003, 55:329-347. 10.1016/S0169-409X(02)00228-4 12628320
33. Muller M Voros J Csucs G Walter E Danuser G Merkle HP Spencer ND Textor M Surface modification of PLGA microspheres J Biomed Mater Res A 2003, 66:55-61. 10.1002/jbm.a.10502 12833431
34. Panyam J Zhou WZ Prabha S Sahoo SK Labhasetwar V Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery FASEB J 2002, 16: 1217-1226. 10.1096/ fj.02-0088com 12153989
35. Bivas-Benita M Romeijn S Junginger HE Borchard G PLGA-PEI nanoparticles for gene delivery to pulmonary epithelium Eur J Pharm Biopharm 2004, 58:1-6. 10.1016/j.ejpb.2004.03.008 15207531
36. Shakweh M Fattal E Design and characterisation of poly(lactide-co-glycolide) small particulate systems for the delivery of immunostimulant CpG oligonucleotide J Nanosci Nanotechnol 2006, 6:2811-2820. 10.1166/jnn.2006.438 17048487
37. Moffatt S Cristiano RJ Uptake characteristics of NGR-coupled stealth PEI/ pDNA nanoparticles loaded with PLGA-PEG-PLGA tri-block copolymer for targeted delivery to human monocyte-derived dendritic cells Int J Pharm 2006, 321:143-154. 10.1016/j.ijpharm.2006.05.007 16860501
38. Oster CG Wittmar M Bakowsky U Kissel T DNA nano-carriers from biodegradable cationic branched polyesters are formed by a modified solvent displacement method J Control Release 2006, 111:371-381. 10.1016/ j.jconrel.2005.12.004 16499988
39. De Rosa G Bochot A Quaglia F Besnard M Fattal E A new delivery system for antisense therapy: PLGA microspheres encapsulating oligonucleotide/ polyethyleneimine solid complexes Int J Pharm 2003, 254:89-93. 10.1016/ S0378-5173(02)00689-0 12615416
40. Yoshimura M Sakamoto M Ikemoto M Mochizuki Y Yuasa K Miyagoe-Suzuki Y Takeda S AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype Mol Ther 2004, 10:821-828. 10.1016/j.ymthe.2004.07.025 15509500
41. Hsu YY Hao T Hedley ML Comparison of process parameters for microencapsulation of plasmid DNA in poly(D,L-lactic-co-glycolic) acid microspheres J Drug Target 1999, 7:313-323. 10682910
42. Oster CG Kissel T Comparative study of DNA encapsulation into PLGA microparticles using modified double emulsion methods and spray drying techniques J Microencapsul 2005, 22:235-244. 10.1080/02652040500100295 16019909
43. Howard KA Li XW Somavarapu S Singh J Green N Atuah KN Ozsoy Y Seymour LW Alpar HO Formulation of a microparticle carrier for oral polyplex-based DNA vaccines Biochim Biophys Acta 2004, 1674:149-157. 15374619
44. Walter E Merkle HP Microparticle-mediated transfection of non-phagocytic cells in vitro J Drug Target 2002, 10:11-21. 10.1080/10611860290007478 11996082
45. Vasir JK Labhasetwar V Biodegradable nanoparticles for cytosolic delivery of therapeutics Adv Drug Deliv Rev 2007, 59:718-728. 2002520 17683826 10.1016/j.addr.2007.06.003
46. Patil Y Panyam J Polymeric nanoparticles for siRNA delivery and gene silencing Int J Pharm 2009, 367(1-2):195-203. Epub 2008 Oct 1 10.1016/ j.ijpharm.2008.09.039 18940242
47. Glodde M Sirsi SR Lutz GJ Physiochemical Properties of Low and High Molecular Weight PEG-Grafted Poly(ethylene imine) Copolymers and their Complexes with Oligonucleotides Biomacromolecules 2006, 7(1):347-356. 10.1021/bm050726t 16398535
48. Cohen-Sacks H Najajreh Y Tchaikovski V Gao G Elazer V Dahan R Gati I Kanaan M Waltenberger J Golomb G Novel PDGFbetaR antisense encapsulated in polymeric nanospheres for the treatment of restenosis Gene Ther 2002 9:1607-1616. 10.1038/sj.gt.3301830 12424613
49. De Rosa G Quaglia F La Rotonda MI Appel M Alphandary H Fattal E Poly(lactide-co-glycolide) microspheres for the controlled release of oligonucleotide/polyethylenimine complexes J Pharm Sci 2002, 91:790-799. 10.1002/jps.10063 11920765
50. Lu QL Rabinowitz A Chen YC Yokota T Yin H Alter J Jadoon A Bou-Gharios G Partridge T From the Cover: Systemic delivery of antisense oligoribonucleotide restores dystrophin expression in body-wide skeletal muscles Proc Natl Acad Sci USA 2005, 102:198-203. 544058 15608067 10.1073/pnas.0406700102
51. Lu QL Mann CJ Lou F Bou-Gharios G Morris GE Xue SA Fletcher S Partridge TA Wilton SD Functional amounts of dystrophin produced by skipping the mutated exon in the mdx dystrophic mouse Nat Med 2003, 9:1009-1014. 10.1038/nm897 12847521
52. Gebski BL Mann CJ Fletcher S Wilton SD Morpholino antisense oligonucleotide induced dystrophin exon 23 skipping in mdx mouse muscle Hum Mol Genet 2003, 12:1801-1811. 10.1093/hmg/ddg196 12874101
53. Capan Y Woo BH Gebrekidan S Ahmed S DeLuca PP Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA J Control Release 1999, 60:279-286. 10.1016/S0168-3659(99)00076-0 10425333